Skip to content
drillr.ai
Sign up

NSPR

InspireMD, Inc.

NASDAQ · Healthcare · Medical - Devices · IL

$0.77
+1.37%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+11.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 29, 2026Stuka Paul · directorPurchase20,000$0.88
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale7,186$2.51
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale5,132$2.46
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale9,923$2.55
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale10,000$3.65
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale3,760$2.51
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale7,073$2.51
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale2,941$1.59
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale2,454$2.51
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale1,572$2.51
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale3,660$2.46
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale2,476$2.61
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale22,778$1.01
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale3,858$2.71
May 21, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale2,482$2.51
May 15, 2026Stuka Paul · directorPurchase10,000$1.16
May 15, 2026Stuka Paul · directorPurchase5,000$1.15
May 13, 2026Slosman Marvin · director, officer: CEO and PresidentPurchase21,000$1.20
May 12, 2026Stuka Paul · directorPurchase10,000$1.19
May 12, 2026Stuka Paul · directorPurchase65,626$1.16
May 8, 2026Stuka Paul · directorPurchase6,378$1.15
May 8, 2026ROUBIN GARY S · directorPurchase90,000$1.18
May 8, 2026Ward Scott R. · directorPurchase73,255$1.15
May 8, 2026Ward Scott R. · directorPurchase15,995$1.15
May 8, 2026Stuka Paul · directorPurchase1,517$1.12
Feb 2, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale5,000$1.65
Feb 2, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale12,395$1.65
Feb 2, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale4,781$1.66
Feb 2, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale8,411$1.57
Feb 2, 2026Gleason Shane Thomas · officer: Chief Commercial OfficerSale17,593$1.62
Institutional positioning

13F filings over the trailing two quarters

New 11Increased 14Reduced 16Sold out 5
FilerActionSharesFiled
Rosalind Advisors, Inc.Unchanged3,905,743Aug 14, 2026
ROSALIND ADVISORS, INC.Unchanged3,905,743May 14, 2026
Aberdeen Group plcIncreased3,698,364Jul 31, 2026
Nantahala Capital Management, LLCUnchanged3,376,484Aug 19, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged3,376,484May 15, 2026
ABRDN PLCUnchanged3,173,364Apr 29, 2026
ORBIMED ADVISORS LLCUnchanged3,133,405May 15, 2026
ORBIMED ADVISORS LLCUnchanged3,133,405Aug 14, 2026
PARKMAN HEALTHCARE PARTNERS LLCUnchanged2,416,518May 15, 2026
Parkman Healthcare Partners LLCUnchanged2,416,518Aug 14, 2026
VELAN CAPITAL INVESTMENT MANAGEMENT LPReduced2,099,652May 15, 2026
MARSHALL WACE, LLPUnchanged1,860,405May 15, 2026
MARSHALL WACE, LLPUnchanged1,860,405Aug 13, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.Reduced1,045,708May 14, 2026
Soleus Capital Management, L.P.Unchanged1,045,708Aug 11, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 29, 2026